Invenomic Capital Management’s Fiserv Inc FISV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$25.5M Sell
520,236
-104,755
-17% -$5.85M 1.52% 21
2026
Q1
$34.9M Buy
624,991
+337,725
+118% +$20.9M 1.6% 16
2025
Q4
$19.3M Buy
+287,266
New +$24M 0.9% 38
2023
Q3
Sell
-65,504
Closed -$8.26M 154
2023
Q2
$8.26M Sell
65,504
-137,656
-68% -$16.2M 0.42% 66
2023
Q1
$23M Buy
203,160
+121,118
+148% +$13.3M 1.3% 26
2022
Q4
$8.29M Sell
82,042
-39,062
-32% -$3.89M 0.56% 60
2022
Q3
$11.3M Sell
121,104
-3,432
-3% -$350K 0.97% 37
2022
Q2
$11.1M Buy
124,536
+41,095
+49% +$3.99M 0.79% 43
2022
Q1
$6.98M Buy
83,441
+49,303
+144% +$4.99M 0.74% 40
2021
Q4
$3.54M Buy
+34,138
New +$3.53M 0.76% 51

Other funds holding FISV

Invenomic Capital Management's FISV Position: Q2 2026 in Review

Invenomic Capital Management reduced its Fiserv Inc (FISV) stake by 17% in Q2 2026, selling an estimated $5.85M and leaving 520,236 shares worth $25.5M. The position accounts for 1.52% of the portfolio, ranked #21.

Invenomic Capital Management first reported a position in FISV in Q4 2021 and has held it in 10 quarters since. The position peaked at $34.9M in Q1 2026. 1,150 funds tracked by Wall St. Rank hold FISV as of Q2 2026.

  • Invenomic Capital Management held 520,236 shares of Fiserv Inc worth $25.5M as of Q2 2026.
  • Invenomic Capital Management sold 104,755 Fiserv Inc shares in Q2 2026, an estimated $5.85M.
  • Fiserv Inc made up 1.52% of Invenomic Capital Management's portfolio in Q2 2026, its #21 holding.
  • Invenomic Capital Management first reported a position in Fiserv Inc in Q4 2021 and has held it in 10 quarters since.
  • Invenomic Capital Management's Fiserv Inc position peaked at $34.9M in Q1 2026.
  • 1,150 funds tracked by Wall St. Rank held Fiserv Inc as of Q2 2026.

Based on Invenomic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.